New Jersey Medical School Clinical Research Center is the only site in the state participating in a worldwide effort to enroll 3,800 HIV negative individuals in the first Phase 3 HIV vaccine efficacy trial conducted in more than a decade. To read the full article.
Recent Posts
- Scientists Discover How Genetic Risk for Alcoholism Changes Brain Cell Behavior.
- What leaving World Health Organization would mean for US.
- Fears of devastation across NJ health, scientific research if Trump cuts proceed.
- Rutgers Health scores $686K grant to study effects of medicinal cannabis use.
- Bird Flu Basics From a Rutgers Health Infectious Disease Expert.
Categories
- Community (2,144)
- Covid (982)
- CTO Events (6)
- News (2,734)
- Pilots (21)